Incubators & VCs Value proposition
Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie
Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health.
Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of knowledge emerging from the Inserm research laboratories to the industrial world, from invention disclosure to industrial partnerships and startups incorporation.
Inserm Transfert also offers services relating to setting up and managing national, European and international projects, as well as supporting the technology transfer of clinical research and health data/databases.
In 2009, Inserm Transfert and Inserm established an investment fund to finance proofs of concept. In 2005, Inserm Transfert Initiative, a dedicated seed money fund for life sciences, was created. Since 2017 a pathway for pre-entrepreneurship supports researchers/inventors that aspire to become involved in entrepreneurship.
Knowledge Transfer, R&D, Licensing, Partnerships, European & International Research Projetcs, Public Health, techtransfert, valorisation, lifescience, and biotechnologyOriginal language
Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie
Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health.
Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of knowledge emerging from the Inserm research laboratories to the industrial world, from invention disclosure to industrial partnerships and startups incorporation.
Inserm Transfert also offers services relating to setting up and managing national, European and international projects, as well as supporting the technology transfer of clinical research and health data/databases.
In 2009, Inserm Transfert and Inserm established an investment fund to finance proofs of concept. In 2005, Inserm Transfert Initiative, a dedicated seed money fund for life sciences, was created. Since 2017 a pathway for pre-entrepreneurship supports researchers/inventors that aspire to become involved in entrepreneurship.
Inserm Transfert - Accueil
Inserm Transfert, fondée en 2000, est la filiale privée de l’Inserm spécialisée dans le transfert de technologies en sciences de la vie
http://www.inserm-transfert.fr/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 5 Nov 2018 12 Feb 2024 | | |
 Eurostat European Union, Environmental Services | Eurostat European Union, Environmental Services | Other 17 Jan 2020 14 Feb 2024 | | |
 La Tribune Media, Newspapers | La Tribune Media, Newspapers | Other 3 Sep 2020 | | |
 Amgen Biotechnology, Biotechnology Research | Amgen Biotechnology, Biotechnology Research | Other 22 Jan 2021 | | |
 Institut Curie Health, Hospitals and Health Care | Institut Curie Health, Hospitals and Health Care | Other 9 Feb 2021 6 Dec 2022 | | |
 Kurma Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Kurma Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 25 Jun 2021 | | |
 CEA Research | CEA Research | Other 23 Sep 2021 12 Oct 2023 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 23 Sep 2021 21 Mar 2024 | | |
 SATT Paris-Saclay Research, Startup accelerator & VC, Research Services | SATT Paris-Saclay Research, Startup accelerator & VC, Research Services | Other 24 Sep 2021 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 4 Feb 2022 16 May 2023 | | |